Skip to main content
Premium Trial:

Request an Annual Quote

Solvay Licenses Genomatix s BibliospherePE Technology

NEW YORK, Aug. 5 (GenomeWeb News) - Solvay Pharmaceuticals has licensed Genomatix Software's BibliospherePE pathway knowledge base and analysis system, the company said yesterday.

BiblioSpherePE helps create data-driven network/pathway construction and analyses based on literature, data in the Genomatix Knowledge Base Ontology, and promoter sequence analysis, Genomatix said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.